Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
February 21, 2004
Partitioning-defective protein 6 regulates insulin-dependent glycogen synthesis via atypical protein kinase C
Peter Weyrich, Katja Kapp, Gerhard Niederfellner, et al.
Molecular and Biochemical Parasitology
|
November 24, 2004
The Schistosoma mansoni Src kinase TK3 is expressed in the gonads and likely involved in cytoskeletal organization
Katja Kapp, Jürgen Knobloch, Peter Schüssler, et al.
Molecular Biology of the Cell
|
March 24, 2006
The kinesin KIF1C and microtubule plus ends regulate podosome dynamics in macrophages
Petra Kopp, Reiner Lammers, Martin Aepfelbacher, et al.
Annals of the New York Academy of Sciences
|
June 12, 2003
CDCP1 is a novel marker for hematopoietic stem cells
Tim Conze, Reiner Lammers, Selim Kuci, et al.
International Journal of Cancer
|
May 8, 2009
The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis
Alexandra Dieterle, Ronald Orth, Merle Daubrawa, et al.
Diabetes
|
January 29, 2005
Insulin glulisine: insulin receptor signaling characteristics in vivo
Anita M Hennige, Rainer Lehmann, Cora Weigert, et al.
The Journal of Biological Chemistry
|
June 27, 2003
Protein kinase C delta induces Src kinase activity via activation of the protein tyrosine phosphatase PTP alpha
Dominique T Brandt, Axel Goerke, Marion Heuer, et al.
The Journal of Biological Chemistry
|
April 8, 2004
Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1
Klaus Moeschel, Alexander Beck, Cora Weigert, et al.
Molecular Oncology
|
September 24, 2013
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy
Gwendlyn Kollmorgen, Gerhard Niederfellner, Alexander Lifke, et al.
Stem Cells (Dayton, Ohio)
|
May 22, 2004
CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin
Hans-Jörg Bühring, Selim Kuçi, Tim Conze, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Molecular Endocrinology (Baltimore, Md.)
|
February 21, 2004
Partitioning-defective protein 6 regulates insulin-dependent glycogen synthesis via atypical protein kinase C
Peter Weyrich, Katja Kapp, Gerhard Niederfellner, et al.
Molecular and Biochemical Parasitology
|
November 24, 2004
The Schistosoma mansoni Src kinase TK3 is expressed in the gonads and likely involved in cytoskeletal organization
Katja Kapp, Jürgen Knobloch, Peter Schüssler, et al.
Molecular Biology of the Cell
|
March 24, 2006
The kinesin KIF1C and microtubule plus ends regulate podosome dynamics in macrophages
Petra Kopp, Reiner Lammers, Martin Aepfelbacher, et al.
Annals of the New York Academy of Sciences
|
June 12, 2003
CDCP1 is a novel marker for hematopoietic stem cells
Tim Conze, Reiner Lammers, Selim Kuci, et al.
International Journal of Cancer
|
May 8, 2009
The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis
Alexandra Dieterle, Ronald Orth, Merle Daubrawa, et al.
Diabetes
|
January 29, 2005
Insulin glulisine: insulin receptor signaling characteristics in vivo
Anita M Hennige, Rainer Lehmann, Cora Weigert, et al.
The Journal of Biological Chemistry
|
June 27, 2003
Protein kinase C delta induces Src kinase activity via activation of the protein tyrosine phosphatase PTP alpha
Dominique T Brandt, Axel Goerke, Marion Heuer, et al.
The Journal of Biological Chemistry
|
April 8, 2004
Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1
Klaus Moeschel, Alexander Beck, Cora Weigert, et al.
Molecular Oncology
|
September 24, 2013
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy
Gwendlyn Kollmorgen, Gerhard Niederfellner, Alexander Lifke, et al.
Stem Cells (Dayton, Ohio)
|
May 22, 2004
CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin
Hans-Jörg Bühring, Selim Kuçi, Tim Conze, et al.
Page
of 3